NOMIS BAY LTD. - 31 Dec 2020 Form 5 Insider Report for HUMANIGEN, INC

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 31 Dec 2020
Net transaction value: -$7.5
SEC form: 5
Accepted by SEC: 27 Aug 2021, 18:17:26 UTC
Source filing: View source filing
Reporting owner signature: /s/ Peter Poole

Key filing fact

NOMIS BAY LTD. filed Form 5 for HUMANIGEN, INC on 27 Aug 2021.

Key facts

This page summarizes NOMIS BAY LTD.'s Form 5 filing for HUMANIGEN, INC.
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Aug 2021, 18:17.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$7.5.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HGEN transaction Derivative

Call Option (Obligation to sell)

Sale

Transaction value: $7.5
Shares: -80
Change %: -0%
Price: $0.0938
Shares after: 6,532,433
Date: 13 Oct 2020
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,000
Exercise price: $20.00
Footnotes: F1, F2

HGEN transaction Derivative

Call Option (Obligation to sell)

Expiration of short derivative position

Transaction value: $0
Shares: -80
Change %: -0%
Price: $0.000000
Shares after: 6,532,433
Date: 16 Oct 2020
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,000
Exercise price: $20.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

NOMIS BAY LTD. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On October 16, 2020, the related call option expired worthless.

Footnote F2

Reflects the number of shares of derivative securities beneficially owned by the reporting person after such sale, which was previously included in the total shown in Table I Column 5 of the previous reports on Form 4 filed by the reporting person.